Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 4. Molecular pathogenesis of lung cancer and its molecular targeted therapy.
Sone
S
S
The Third Department of Internal Medicine, Tokushima University School of Medicine.
Shinohara
T
T
Nishioka
Y
Y
Yano
S
S
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D002986:Clinical Trials as Topic / Q000379:methods; D003043:Cocarcinogenesis; D015195:Drug Design; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics / Q000473:pathology; D008222:Lymphokines / Q000037:antagonists & inhibitors / Q000502:physiology; D020782:Matrix Metalloproteinases / Q000502:physiology; D008954:Models, Biological; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000502:physiology; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D009857:Oncogenes; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000502:physiology; D017978:Receptors, Growth Factor / Q000037:antagonists & inhibitors / Q000502:physiology; D040262:Receptors, Vascular Endothelial Growth Factor; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D016228:Endothelial Growth Factors; D008222:Lymphokines; D009363:Neoplasm Proteins; D017978:Receptors, Growth Factor; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D020794:Receptor Protein-Tyrosine Kinases; D040262:Receptors, Vascular Endothelial Growth Factor; D020782:Matrix Metalloproteinases